Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 04 09 2023
revised: 13 11 2023
accepted: 22 11 2023
medline: 11 12 2023
pubmed: 24 11 2023
entrez: 23 11 2023
Statut: ppublish

Résumé

Bronchoalveolar lavage fluid (BALF) is a standard respiratory sample for diagnosing invasive fungal diseases like Pneumocystis pneumonia (PCP) and invasive pulmonary aspergillosis (IPA). However, procedural variations exist across medical centers and wards. This study aimed to compare the diagnostic potential of BALF and bronchial aspirate (BA) obtained during bronchoscopy in 173 patients suspected of fungal infections. A prospective observational study was conducted from April 2020 to November 2021. BALF and BA were collected during bronchoscopy and subjected to direct examination, fungal culture, Aspergillus fumigatus qPCR (AfqPCR), and Pneumocystis jirovecii qPCR (PjqPCR). Galactomannan detection was performed on BALF. Patients were classified based on established European Organization for Research and Treatment of Cancer (EORTC) criteria. Out of 173 patients, 75 tested positive for at least one test in BA or BALF. For Aspergillus, proportion of positive AfqPCR (14.5% vs. 9.2%; P < 0.0001) and fungal loads (Cq of 31.3 vs. 32.8; P = 0.0018) were significantly higher in BA compared to BALF. For Pneumocystis, fungal loads by PjqPCR was also higher in BA compared to BALF (Cq of 34.2 vs. 35.7; P = 0.003). BA only detected A. fumigatus and P. jirovecii in 12 (42.9%) and 8 (19.5%) patients, respectively. BA obtained during a BAL procedure can be a suitable sample type for increased detection of P. jirovecii and A. fumigatus by qPCR. The use of BA in diagnostic algorithms requires further investigation in prospective studies. Bronchoalveolar lavage fluid (BALF) vs. bronchial aspirate (BA) for fungal diagnosis in 173 patients suspected of invasive fungal infection: BA showed higher fungal loads than in BALF by qPCR for the detection of Aspergillus fumigatus and Pneumocystis jirovecii.

Autres résumés

Type: plain-language-summary (eng)
Bronchoalveolar lavage fluid (BALF) vs. bronchial aspirate (BA) for fungal diagnosis in 173 patients suspected of invasive fungal infection: BA showed higher fungal loads than in BALF by qPCR for the detection of Aspergillus fumigatus and Pneumocystis jirovecii.

Identifiants

pubmed: 37996394
pii: 7444998
doi: 10.1093/mmy/myad120
pii:
doi:

Substances chimiques

Mannans 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Sarah Dellière (S)

Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France.
Institut Pasteur, Université de Paris Cité, Immunobiology d'Aspergillus, Paris, France.

Yaël Amar (Y)

Service de pneumologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Samia Hamane (S)

Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Nesrine Aissaoui (N)

Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Blandine Denis (B)

Service d'infectiologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Anne Bergeron (A)

Hôpitaux Universitaire de Genève, University of Geneva, Genève, Switzerland.

Abdellatif Tazi (A)

Service de pneumologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Alexandre Alanio (A)

Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France.
Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology research group, Mycology Department, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH